Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that senior management will participate in the BTIG Emerging Technologies in Healthcare Diagnostics conference. Transgenomic’s Executive Vice President and Chief Financial Officer Mark Colonnese will discuss Personalized Medicine in the CLIA Lab on Monday, September 29, 2014 at 4:10 pm ET.
Help employers find you! Check out all the jobs and post your resume.
